Introduction. The higher complication rate associated with the surgical treatment of restenosis following carotid endarterectomy (CEA) has led several authors to advocate angioplasty as the treatment of choice in the management of restenosis. We describe our experience with internal carotid artery angioplasty for post-endarterectomy restenosis over 7 years. Patients and methods. From January 1994 to April 2001, all patients with a . 90% restenosis following CEA were considered for angioplasty. Thirty angioplasties were carried out in 25 patients, 80% (24/30), for asymptomatic recurrent stenosis. There was no difference between those who had intervention for recurrent stenosis (n ¼ 31) and those who did not (n ¼ 545) in age, sex, smoking status or incidence of diabetes or hypertension. A significantly greater number of patients who underwent angioplasty were hypercholesterolaemic (p , 0.05, Chi-squared test). Results. Mean time from surgery to angioplasty was 13 months (range 1-23). Angioplasty was technically successful in 29 cases (97%). Three patients (10%) experienced transient neurological symptoms during the procedure. There were no strokes. Ninety-six percent (28/29) of patients were followed up with duplex scanning. Mean follow-up was 20 months (range 2 -48). Three patients developed a greater than 90% restenosis. Conclusion. Angioplasty is an acceptable alternative to surgery in the management of internal carotid artery restenosis following endarterectomy.
Introduction
Recurrent stenosis of the internal carotid artery occurs in up to 15% of patients following carotid endarterectomy (CEA).
1,2 Avramovic reported that 7.4% of patients who develop ipsilateral neurological events following CEA have recurrent stenosis, 3 prompting treatment of these lesions.
Morbidity rates relating to surgery for restenosis of the internal carotid artery are higher than those of endarterectomy for primary lesions. 4 -7 Scar tissue at the arteriotomy site makes the dissection more traumatic and a true plane of cleavage between the recurrent lesion and the vessel wall is often illdefined. 5 A recent comparison of 547 primary carotid endarterectomies with 124 redo procedures revealed a perioperative stroke rate of 4.8% in those undergoing reoperation versus just 0.8% in the primary endarterectomy group. 7 The same study also reported significantly higher rates of cranial nerve injury in the reoperation group-17% versus 5.3%. 7 The increased incidence of complications has led some authors to advocate the use of percutaneous transluminal angioplasty in the management of this condition. 6, 8 Two randomised trials have demonstrated equivalent stroke and death rates for surgical and endovascular management of primary carotid stenosis. 9, 10 The lesion associated with primary carotid stenosis is histologically different from that seen following early restenosis, 11 making extrapolation of the results of these trials to patients with restenosis difficult. Early restenosis (within 2 years of CEA) of the internal carotid artery is usually due to fibrointimal hyperplasia while later (over 2 years after CEA) restenosis is commonly attributed to recurrent atherosclerotic plaque. 11 It is hypothesised that the smooth fibrous lesion of early restenosis is at a significantly lower risk of distal embolisation than a friable atherosclerotic plaque.
This study describes our experience with internal carotid artery angioplasty in the management of patients with a recurrent stenosis of the internal carotid artery following endarterectomy.
Patients and Methods
From January 1994 to April 2001 571 consecutive carotid endarterectomies were performed at the Mater Hospital. The mean age of the patients was 66 years (range 43 -84 years) and 206 (36%) were female. All patients referred to the unit with a greater than 70% symptomatic stenosis or a greater than 90% asymptomatic stenosis were considered for surgery. Asymptomatic patients accounted for 165 (29%) of the endarterectomies performed. A policy of selective shunting based on a carotid stump pressure of less than 50 mmHg is employed during CEA. Patching of the carotid artery was used in only four cases in this series ( Table 1 ). The overall stroke and death rate for the series was 2.1%.
All patients were entered prospectively onto a database and followed-up post-operatively with duplex ultrasonography at 1, 3, 6, 12 and 24 months. All patients with greater than 90% restenosis, at the site of the previous endarterectomy were considered for endovascular intervention. Thirty internal carotid artery angioplasties were attempted on 25 patients for severe (. 90%) restenosis during this period. Angioplasty was attempted for symptomatic restenosis in six (20%) cases. Of these six cases, three patients presented with TIAs, two had amaurosis fugax and one had a minor CVA with good recovery.
Carotid angioplasty was performed by a single consultant radiologist. From the common femoral artery a 6 mm balloon catheter was exchanged over a guidewire and inflated for 30 s at the site of the restenosis. Different size balloons were available if needed but in all cases a satisfactory result was achieved with the 6 mm device. Cerebral protection devices or endovascular stents were not employed in this series.
Following angioplasty, patients were recommenced on aspirin and re-entered the carotid surveillance programme, with duplex scanning at 3, 6, 12 and 24 months.
Statistical analysis was performed using a Toshibae Satellite 2060 CDS Computer with GB-STAT version 6.5 statistical package (Dynamic Microsystems Inc.). Categorical data was compared using the Chi-squared test. A pvalue of less than 0.05 was considered significant.
Results
Twenty-nine of 30 procedures were technically successful (97%). The unsuccessful case was due to a failure to cross the lesion with the guidewire. The patient was subsequently treated by CEA. Of the 25 patients treated, one patient underwent angioplasty of the contralateral side 6 months following the initial procedure. Three patients required repeat angioplasty for restenosis following the original intervention, one of whom needed a third angioplasty.
All procedures were carried out within 2 years of surgery. Mean time from surgery to angioplasty was 13 months (range 1-23 months).
One patient died from a myocardial infarction within 30 days of undergoing carotid angioplasty. No patient suffered a stroke as a consequence of undergoing carotid angioplasty. Three patients (10%) had a transient neurological event, manifesting as contralateral limb weakness during the procedure, which completely resolved within minutes. Just one of these patients was symptomatic prior to angioplasty.
Twenty-eight of the 29 successful procedures (96%) were followed up post-angioplasty. One patient had died from a myocardial infarction before his first follow-up duplex scan. The average follow-up period was 20 months (range 2-48). Three patients (10%) developed a greater than 90% restenosis. All underwent repeat angioplasty and two had a less than 60% stenosis on their most recent follow-up scan. One of these patients required a third angioplasty for an asymptomatic . 90% restenosis. There were two groin haematomas (6%). There was no significant difference between those who required angioplasty following endarterectomy ðn ¼ 30Þ and those who did not ðn ¼ 545Þ in terms of age, sex, smoking status, intra-operative shunting, patching of the carotid artery or incidence of diabetes or hypertension (see Table 1 ). The group of patients who required angioplasty for critical restenosis contained a significantly greater proportion of patients with hypercholesterolaemia than those who needed no further intervention following surgery (p , 0:05; Chi-squared test).
Discussion
The incidence of neurological complications in this series is in keeping with that reported elsewhere in the literature 6, 12, 13 (Table 2 ). Our results demonstrate that angioplasty is an alternative to re-operation in the management of carotid artery restenosis but has its own associated morbidity.
The 10% stroke and death rate quoted in the largest randomised controlled trial of primary carotid angioplasty published to date has caused some to doubt the suitability of this procedure for managing primary carotid stenosis. 10 Early restenoses detected within the first two years are usually due to fibrointimal hyperplasia and therefore less likely to embolise during balloon angioplasty than the friable atherosclerotic plaque characteristic of primary carotid stenosis. 11, 14 Transient neurological events occurred during the procedure in three cases (10%). As these all resolved before the patient left the radiology suite, it is unclear, whether they were due to either embolisation or transient arrest in blood flow in the internal carotid artery during inflation of the balloon. No cerebral protection devices were employed during any of the procedures as carotid angioplasty in our unit began at a time when cerebral protection was not available. Plaque debris has been demonstrated in the cerebral protection devices of over 50% of patients undergoing carotid angioplasty for primary stenosis, lending weight to the argument for routine cerebral protection. 15 The use of cerebral protection devices means using larger guide catheters, with more manipulation in the internal carotid artery and a slightly longer procedure time. The restenoses being treated in this series are smooth fibrointimal lesions and the use of such devices for lesions which are unlikely to embolise may be unnecessary and might even lead to more complications for the reasons outlined above.
No carotid stents were deployed in any of the patients treated in this series. Evidence of improved results from stenting with angioplasty has increased over recent years 9 but was, at best, ambiguous when this series was begun in 1994. In light of more recent reports 9 we should perhaps reconsider our policy regarding the use of stent devices during carotid angioplasty.
Eighty percent of cases in this series were asymptomatic. The discrepancy between this and the proportion of patients undergoing primary CEA who were asymptomatic (29%) is most probably due to the fact that post-endarterectomy, patients were entered into a duplex surveillance programme which undoubtedly detected a greater proportion of asymptomatic high grade stenoses. Most authors are in agreement that symptomatic restenosis warrants intervention but the issue of whether asymptomatic restenoses should be treated or not remains controversial. The possibility of a high grade stenosis progressing to carotid artery occlusion has led us and others to treat these lesions in asymptomatic patients. 16, 17 Significant restenosis following angioplasty occurred in three patients (10%). In their series of 61 patients undergoing carotid intervention for recurrent stenosis, Abu-Rahma et al. reported a 32% incidence of recurrent stenosis greater than 50%. 18 No patient in this series was stented. In their series of 25 carotid angioplasties for restenosis, Lanzino and colleagues reported a significant restenosis in three of five patients managed with angioplasty alone and just one of the 18 patients who were treated with angioplasty and stenting. 19 In the absence of a randomised controlled trial the issue of whether stent placement would be of benefit in preventing further restenosis remains controversial.
A significantly greater number of patients requiring angioplasty for recurrent stenosis were hypercholesterolaemic compared to those needing no further intervention. Hypercholesterolaemia is a well-recognised risk factor in the development of atherosclerosis and these patients may represent a subgroup of those undergoing CEA who are at higher risk of restenosis. Longer follow up of a larger group of patients is necessary to resolve this issue.
Conclusion
Angioplasty of the internal carotid artery is an acceptable alternative to surgery for the management of restenosis following endarterectomy.
